3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Depression
4
Breast Neoplasms
4
Prostatic Neoplasms
3
Head and Neck Neoplasms
3
Triple Negative Breast Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Fatigue
2
Anxiety Disorders
2
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Smoking Cessation
1
Sleep Wake Disorders
1
Recurrence
1
Radiation Fibrosis Syndrome
1
Prostatic Hyperplasia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Patient Acceptance of Health Care
1
Pain
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Lymphoma, Follicular
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Calculi
1
Inflammatory Breast Neoplasms
1
Immune Checkpoint Inhibitor-Induced Dermatitis
1
Health Education
1
Interventions
ponatinib
3
asciminib
3
nilotinib
2
fludarabine phosphate
2
Whole-Body Irradiation
2
Specimen Handling
2
Melphalan
2
Dasatinib
2
Cyclophosphamide
2
Busulfan
2
venetoclax
1
ruxolitinib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
letermovir
1
Tyrosine Kinase Inhibitors
1
Tacrolimus
1
Stem Cell Transplantation
1
Sirolimus
1
Rituximab
1
Pharmaceutical Preparations
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Methotrexate
1
Interviews as Topic
1
Imatinib Mesylate
1
Etoposide
1
Cyclosporine
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Chronic-Phase
×
Therapeutics
×
90 days
×
Clear all
No trials found.